No Data
No Data
Monte Rosa Therapeutics Insider Ups Holding During Year
Insider Purchase: Director at $GLUE Buys 10,000 Shares
Piper Sandler Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Maintains Target Price $20
LifeSci Capital Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Maintains Target Price $19
Wedbush Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Raises Target Price to $17
Monte Rosa Therapeutics Earnings Call Highlights Progress and Strategic Shifts
104687047 : Thank you for your hardwork. Also very good choice to remove your top picks. People should do their own DD and not copy trades like those scam gurus out there
Jaguar8 OP 104687047 : yup so they will decide which one
72812736 : Thank you for your hard and selfless contributions all this time!!!!![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
Dreaming Cat : Thank you for your hard work Sir
Lynn953818 : thank you very much
View more comments...